Lipoprotein (LP) accumulation in the artery wall is a crucial early step in atherogenesis and is thought to result from increased LP flux across the endothelial cell barrier and increased retention of LPS within the subendothelial cell matrix. The factors that control these processes include the amounts and composition of circulating LPS, their interaction with the artery wall, their alteration by endothelial cells (EC) and macrophages, and their association with matrix molecules leading to entrapment within the artery. A central hypothesis of this project is that artery wall lipoprotein lipase (LpL) has a major impact on all of those factors. How LPL impacts, in a proatherogenic way, upon the interaction between Lp and the artery wall will be investigated. This project includes 3 specific aims that will assess atherosclerosis development in genetically altered mice with differences in arterial wall LpL explore how LpL alters macrophage functions: directly assess mechanisms for Lp accumulation in arteries and relate these mechanisms with atherogenic risk in humans.
In Aim 1 atherogenesis will be studied in mice with macrophages that express increased amounts or no LpL. In addition, the effects of increased lipolysis at the artery wall will be determined using transgenic mice with increased arterial wall LpL.
In Aim 2 we will study the biological and pathological roles of macrophage LpL, focusing on the role of fatty acids as an energy source. A second objective will be to study how LpL affects matrix association of other proteoglycan- binding proteins.
Aim 3 proposes to study how Lp size and composition, which are significantly affected by LpL activity, modulate Lp accumulation in normal and atherosclerotic mouse aortas. This information will be correlated with Lp profiles and variants in genes for apolipoproteins and lipid enzymes in humans. This project includes collaborations with all the other projects in this SCOR. With Project 1, we will study the cooperative roles of sphingomyelinase and LpL. With Project 3, we will assess the roles of lipolysis versus CETP in producing atherogenic LPS. Experiments to determine the effects of LpL on production of atherogenic LPS in diabetic mice will involve a collaboration with Projects 3 and 4. Because interferon gamma modulates LpL production by macrophages, several experiments will be done cooperatively with investigators in Project 5. Studies in this Project to determine genetic polymorphisms associated with CHD risk in humans will provide data that will be used in other Projects. All of the proposed core units, including Pathology, Molecular Biology, and Clinical- Biostatistics will be required for these experiments.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL056984-02
Application #
6273212
Study Section
Project Start
1998-04-01
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Chen, Han; Cade, Brian E; Gleason, Kevin J et al. (2018) Multiethnic Meta-Analysis Identifies RAI1 as a Possible Obstructive Sleep Apnea-related Quantitative Trait Locus in Men. Am J Respir Cell Mol Biol 58:391-401
Johnson, Dayna A; Hirsch, Jana A; Moore, Kari A et al. (2018) Associations Between the Built Environment and Objective Measures of Sleep: The Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 187:941-950
Johnson, Dayna A; Lane, Jacqueline; Wang, Rui et al. (2017) Greater Cognitive Deficits with Sleep-disordered Breathing among Individuals with Genetic Susceptibility to Alzheimer Disease. The Multi-Ethnic Study of Atherosclerosis. Ann Am Thorac Soc 14:1697-1705
Cade, Brian E; Chen, Han; Stilp, Adrienne M et al. (2016) Genetic Associations with Obstructive Sleep Apnea Traits in Hispanic/Latino Americans. Am J Respir Crit Care Med 194:886-897
Mayurasakorn, Korapat; Williams, Jill J; Ten, Vadim S et al. (2011) Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia. Curr Opin Clin Nutr Metab Care 14:158-67
Devlin, Cecilia M; Leventhal, Andrew R; Kuriakose, George et al. (2008) Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 28:1723-30
Pan, Meihui; Maitin, Vatsala; Parathath, Sajesh et al. (2008) Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control. Proc Natl Acad Sci U S A 105:5862-7
Williams, Kevin Jon; Feig, Jonathan E; Fisher, Edward A (2008) Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med 5:91-102
Tabas, Ira; Williams, Kevin Jon; Boren, Jan (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:1832-44
Williams, Kevin Jon; Qiu, Gang; Usui, Hitomi Katoaka et al. (2007) Decorin deficiency enhances progressive nephropathy in diabetic mice. Am J Pathol 171:1441-50

Showing the most recent 10 out of 74 publications